Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "City"

1624 News Found

AbbVie wins FDA nod for DECNUPAZ in rare blood cancer
News | May 29, 2026

AbbVie wins FDA nod for DECNUPAZ in rare blood cancer

BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes


Remidio’s InstaEyeClinic wins first position at Andhra Pradesh MedTech Innovation Challenge
Medical Device | May 28, 2026

Remidio’s InstaEyeClinic wins first position at Andhra Pradesh MedTech Innovation Challenge

The device screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient


Asahi Kasei bags breakthrough ADC tech in push for safer & more precise cancer therapies
Technology | May 28, 2026

Asahi Kasei bags breakthrough ADC tech in push for safer & more precise cancer therapies

The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs


Supriya Lifescience posts 50% revenue growth in Q4 FY26; PAT rises to Rs 74 crore
News | May 28, 2026

Supriya Lifescience posts 50% revenue growth in Q4 FY26; PAT rises to Rs 74 crore

On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25


Organ Man of India Nilesh Mandlewala bestowed with Padma Shri
Healthcare | May 28, 2026

Organ Man of India Nilesh Mandlewala bestowed with Padma Shri

Honoured for his immense contribution in the field of social service and organ donation awareness


Morepen Labs posts strong Q4 FY26 net profit
News | May 28, 2026

Morepen Labs posts strong Q4 FY26 net profit

For the full year, standalone gross revenue crossed Rs. 1,700 crore


Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD
Biopharma | May 28, 2026

Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD

Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress


Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz
News | May 27, 2026

Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz

The company highlighted continued demand strength and pricing resilience despite global disruptions


Align Tech to open $200M manufacturing facility in Hyderabad aiming 300+ jobs
Medical Device | May 27, 2026

Align Tech to open $200M manufacturing facility in Hyderabad aiming 300+ jobs

The new facility marks Align’s first manufacturing presence in India and its fourth globally